TY - DATA T1 - Supplementary Material for: Evaluation of the Efficacy of Ultrasound-Guided Local Lauromacrogol Injection Combined with Aspiration for Cesarean Scar Pregnancy: A Novel Treatment PY - 2017/11/28 AU - Chai Z.-Y. AU - Yu L. AU - Liu M.-M. AU - Zhu T.-W. AU - Qi F. UR - https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Evaluation_of_the_Efficacy_of_Ultrasound-Guided_Local_Lauromacrogol_Injection_Combined_with_Aspiration_for_Cesarean_Scar_Pregnancy_A_Novel_Treatment/5640253 DO - 10.6084/m9.figshare.5640253.v1 L4 - https://ndownloader.figshare.com/files/9827101 L4 - https://ndownloader.figshare.com/files/9827110 KW - Cesarean scar pregnancy KW - Lauromacrogol KW - Ultrasound KW - Aspiration N2 - Objectives: To evaluate the efficacy of ultrasound-guided local lauromacrogol injection combined with aspiration for treating cesarean scar pregnancy (CSP). Methods: From July 2016 to December 2016, 18 patients diagnosed with CSP were treated with ultrasound-guided local lauromacrogol injection combined with aspiration. Clinical data and outcome were analysed. Results: All patients were treated successfully. The amount of bleeding ranged between 10 and 50 mL. The duration of hospitalization ranged between 2 and 11 days. Serum β-human chorionic gonadotropin (β-hCG) decreased to the nondetectable level within 19–41 days. Menstruation recovery occurred after 10–24 days of normalization of serum β-hCG level. Reproductive functions were preserved, and there were no untoward effects or complications. Conclusions: Ultrasound-guided local lauromacrogol injection combined with aspiration is an effective CSP therapy, as it was associated with a high success rate, short hospitalization and fast recovery. However, its wider application and popularization have to be validated on a larger patient population affected by CSP. ER -